TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20129332

Group type: EXPERIMENTAL
Intervention: Laparoscopic uterine artery occlusion and myomectomy (LUAO-M)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Laparoscopic surgery supracervical hysterectomy (LSH)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Laparoscopic myomectomy (LM)
Number of subjects: 90
Study: 17660482

Group type: EXPERIMENTAL
Intervention: vildagliptin 100 mg qd
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: digoxin (0.5 mg, then 0.25 mg qd on days 2‐7)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: combination vildagliptin/digoxin for 7 days
Number of subjects: 18
Study: 16207773

Group type: EXPERIMENTAL
Intervention: Social monitoring (attention to social information and cues)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decoding of social cues in faces and voices
Number of subjects: 0
Study: 12381481

Group type: EXPERIMENTAL
Intervention: IUD use
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 383
Study: 10999557

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1,000 mg twice daily
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 2,000 mg twice daily
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1,000 mg and 2,000 mg
Number of subjects: 324
Study: 8963746

Group type: EXPERIMENTAL
Intervention: Proprioceptive training (20 min per day, 5 phases of increasing difficulty over three soccer seasons)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (normal training, no special balance training)
Number of subjects: 600
Study: 1599635

Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplementation (1 g for 12 weeks)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplementation continued for 36 weeks after initial 12 weeks if blood pressure decreased by at least 5 mm Hg
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo (4 weeks followed by 12 weeks run-out)
Number of subjects: 103
Study: 3830333

Group type: EXPERIMENTAL
Intervention: Type 1 electroconvulsive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 2 electroconvulsive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 3 electroconvulsive therapy
Number of subjects: 0
Study: 31390289

Group type: EXPERIMENTAL
Intervention: language‐focused intervention
Number of subjects: 938

Group type: COMPARATOR
Intervention: business‐as‐usual control
Number of subjects: 938
Study: 29980177

Group type: EXPERIMENTAL
Intervention: Tailored, theory informed knowledge translation (KT) interventions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual dissemination practices
Number of subjects: 24
Study: 26763605

Group type: EXPERIMENTAL
Intervention: OFDI-guided PCI
Number of subjects: 0

Group type: COMPARATOR
Intervention: IVUS-guided PCI
Number of subjects: 0
Study: 24239386

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard radiation therapy
Number of subjects: 151
Study: 22527168

Group type: EXPERIMENTAL
Intervention: Dairy product intake (1 SD increase)
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Dairy protein intake (1 SD increase)
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Calcium intake (25% increase)
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Selenium intake (25% increase)
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Animal protein intake (1 SD increase)
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Dairy protein and calcium intake
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Dietary associations with IGFBP-3 or IGF-II
Number of subjects: 1798
Study: 20154071

Group type: EXPERIMENTAL
Intervention: Helmet CPAP
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard oxygen therapy (control)
Number of subjects: 47
Study: 18621791

Group type: EXPERIMENTAL
Intervention: Bimatoprost once daily
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Bimatoprost twice daily/once daily
Number of subjects: 152

Group type: COMPARATOR
Intervention: Timolol twice daily
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 152

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 152
Study: 15752661

Group type: EXPERIMENTAL
Intervention: Bishop score
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Ultrasonographic cervical length
Number of subjects: 266
Study: 12050495

Group type: EXPERIMENTAL
Intervention: Mistletoe lectin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 45
Study: 10471604

Group type: EXPERIMENTAL
Intervention: Aerosol ribavirin
Number of subjects: 41

Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 41
Study: 8946267

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (C, E, beta-carotene)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31268266

Group type: EXPERIMENTAL
Intervention: 25G Sprotte needle
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: 27G Sprotte needle
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: 26G Atraucan needle
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: 25G Quincke needle (midline approach)
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: 25G Quincke needle (paramedian approach)
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Midline approach
Number of subjects: 655

Group type: COMPARATOR
Intervention: Paramedian approach
Number of subjects: 655
Study: 28733256

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control experiment (order-irrelevant font color classification)
Number of subjects: 48
Study: 25301853

Group type: EXPERIMENTAL
Intervention: Scheduled second-look endoscopy (SLE)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Non-SLE (control group)
Number of subjects: 262
Study: 24095905

Group type: EXPERIMENTAL
Intervention: Lowest decile of dietary folate intake
Number of subjects: 1153
Study: 21059740

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFAs) 3 g/day until ECV and 2 g/day thereafter
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 18664159

Group type: EXPERIMENTAL
Intervention: Cryosurgery followed by diclofenac sodium 3% gel for 90 days
Number of subjects: 714

Group type: COMPARATOR
Intervention: Cryosurgery alone
Number of subjects: 714
Study: 15677892

Group type: EXPERIMENTAL
Intervention: Mediterranean dietary pattern (high consumption of olive oil, vegetables, fruit, fish, and lean meat)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Western dietary pattern
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Snacks dietary pattern
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Sweets and snacks dietary pattern
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: High fat and proteins dietary pattern
Number of subjects: 442
Study: 12870375

Group type: EXPERIMENTAL
Intervention: Rice-hydrolysate formula (n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Soy formula (control group, n = 8)
Number of subjects: 16
Study: 10848660

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 232
Study: 8803370

Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 or 4 mg)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 269
Study: 1735350

Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 6697270

Group type: EXPERIMENTAL
Intervention: Granulocyte transfusions
Number of subjects: 43

Group type: COMPARATOR
Intervention: No granulocyte transfusions (Control)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Amphotericin B
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Fungal infections
Number of subjects: 43
Study: 30218263

Group type: EXPERIMENTAL
Intervention: da Vinci Single-Site™ cholecystectomy (dVSSC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single-Port Laparoscopic Cholecystectomy (SILC)
Number of subjects: 60
Study: 29861216

Group type: EXPERIMENTAL
Intervention: Cervical mobilization
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 30
Study: 26607696

Group type: EXPERIMENTAL
Intervention: Manual chest compressions on concrete floor
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Manual chest compressions on firm standard mattress
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Manual chest compressions on pressure-relieving mattress
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mechanical chest compressions on concrete floor
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mechanical chest compressions on firm standard mattress
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mechanical chest compressions on pressure-relieving mattress
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Manual CPR
Number of subjects: 24
Study: 23943282

Group type: EXPERIMENTAL
Intervention: Topical 0.4 % glyceryl trinitrate (GTN) ointment every 12 hours for four postoperative weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no GTN ointment)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Topical 0.4 % glyceryl trinitrate (GTN) ointment
Number of subjects: 104
Study: 22504093

Group type: EXPERIMENTAL
Intervention: Abatacept 30 mg/kg
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Abatacept 10 mg/kg
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Abatacept 3 mg/kg
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 451
Study: 20140448

Group type: EXPERIMENTAL
Intervention: Acupuncture (dry needling) for 10 min
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Heating (application of hot pack) for 10 min
Number of subjects: 9
Study: 19796735

Group type: EXPERIMENTAL
Intervention: High-dose statin therapy initiated pre-discharge
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose statin therapy
Number of subjects: 0
Study: 16435697

Group type: EXPERIMENTAL
Intervention: Two-talker AV configurations with zero, one, or two channels of visual information combined with zero, one, or two channels of audio information.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual representation of only a single talker.
Number of subjects: 0
Study: 12915639

Group type: EXPERIMENTAL
Intervention: 30% protein diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: 15% protein diet
Number of subjects: 0
Study: 10482346

Group type: EXPERIMENTAL
Intervention: Sleep deprivation (three cycles)
Number of subjects: 206
Study: 8790125

Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin
Number of subjects: 8
Study: 2006775

Group type: EXPERIMENTAL
Intervention: PuriDyne units with active filters
Number of subjects: 12

Group type: COMPARATOR
Intervention: Units with inactive filters
Number of subjects: 12
Study: 7048859

Group type: EXPERIMENTAL
Intervention: Stereotactic anterior capsulotomy
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Cingulotomy
Number of subjects: 4
Study: 31949092

Group type: EXPERIMENTAL
Intervention: Formulated eye drop with Leptospermum spp honey
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control eye drops (Alcon, USA)
Number of subjects: 46
Study: 29890670

Group type: EXPERIMENTAL
Intervention: Improved outer packaging
Number of subjects: 1149

Group type: EXPERIMENTAL
Intervention: Improved outer packaging combined with cooking demonstrations
Number of subjects: 1149

Group type: COMPARATOR
Intervention: Original outer packaging
Number of subjects: 1149
Study: 27611753

Group type: EXPERIMENTAL
Intervention: Symmetric natural functional tooth units
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asymmetric artificial functional tooth units
Number of subjects: 0
Study: 25190442

Group type: EXPERIMENTAL
Intervention: Ovoid/Spheroid shape
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Slab shape
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Stick shape
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Multicomponent shape
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Infarct volume
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Vascular risk factors
Number of subjects: 1679
Study: 22413944

Group type: EXPERIMENTAL
Intervention: CZP 200 mg
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: CZP 400 mg
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 20391072

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) program, 6-week duration
Number of subjects: 69

Group type: COMPARATOR
Intervention: Educational control group
Number of subjects: 69
Study: 18853940

Group type: EXPERIMENTAL
Intervention: Portable monitoring (PM) and unattended autotitrating positive airway pressure (APAP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 106
Study: 16471103

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 61

Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 61
Study: 12579144

Group type: EXPERIMENTAL
Intervention: Open scaphocapitate fusion and lunate revascularization
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fully arthroscopic scaphocapitate fusion and capitate pole excision
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study: 10912689

Group type: EXPERIMENTAL
Intervention: Hyaluronan-based biomembrane
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study: 9295487

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ergotocin
Number of subjects: 60
Study: 1906746

Group type: EXPERIMENTAL
Intervention: Prophylactic administration of OKT3
Number of subjects: 0
Study: 6824997

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and pyloroplasty (TVP)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Highly selective vagotomy (HSV)
Number of subjects: 153
Study: 30890115

Group type: EXPERIMENTAL
Intervention: Acute stenting of the cervical internal carotid artery
Number of subjects: 162

Group type: COMPARATOR
Intervention: Not applicable (no specific control intervention mentioned)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Not applicable (no specific intervention mentioned)
Number of subjects: 162
Study: 29170901

Group type: EXPERIMENTAL
Intervention: Phototherapy
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Exercise Training (EXT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Combined therapy (Phototherapy + EXT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 160
Study: 28199697

Group type: EXPERIMENTAL
Intervention: Early adenotonsillectomy (eAT)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 380
Study: 26561614

Group type: EXPERIMENTAL
Intervention: Hypocaloric low glycemic index (LGI) diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 23694840

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1000 IU/d)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 21508724

Group type: EXPERIMENTAL
Intervention: Plate fixation (group I, n=5)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Double screw technique (group II)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Single screw technique (group III)
Number of subjects: 15
Study: 18245544

Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 54
Study: 17106146

Group type: EXPERIMENTAL
Intervention: Low energy internal cardioversion (ICV)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Transthoracic cardioversion (TT CV)
Number of subjects: 52
Study: 12574925

Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Open colectomy
Number of subjects: 59
Study: 11115196

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine and acetaminophen
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 430
Study: 9337598

Group type: EXPERIMENTAL
Intervention: Self-directed behavioral family intervention (SD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waitlist control group (WL)
Number of subjects: 24
Study: 8384658

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once a day for 3 days)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Roxithromycin (150 mg every 12 hours for 7 days)
Number of subjects: 51
Study: 3485028

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control
Number of subjects: 98
Study: 29402234

Group type: EXPERIMENTAL
Intervention: Structured follow-up by a GP and home care oncology nurse (HON) including a GP consultation before treatment and a minimum of three contacts with the HON during and after treatment.
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Structured follow-up by a GP and home care oncology nurse (HON).
Number of subjects: 150

Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 150
Study: 27797983

Group type: EXPERIMENTAL
Intervention: Pentax Airway Scope (PAWS)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: GlideScope video laryngoscope (GVL)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Direct laryngoscopy (DL)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 35
Study: 27543065

Group type: EXPERIMENTAL
Intervention: Qigong/Tai Chi Easy (QG/TCE)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Sham Qigong group (SQG)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Educational support (ES) group
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Biomarkers of HPA axis dysregulation (diurnal cortisol)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Biomarkers of inflammation (IL1ra, IL6, TNFα and INFᵧ)
Number of subjects: 250
Study: 22546175

Group type: EXPERIMENTAL
Intervention: Wood smoke exposure at 200 μg/m(3)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Wood smoke exposure at 400 μg/m(3)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clean air (control) exposure
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Wood smoke exposure (all concentrations)
Number of subjects: 20
Study: 21330817

Group type: EXPERIMENTAL
Intervention: Line-of-Sight
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Baseline & Flicker
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Line-of-Sight & Flicker
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Warning Sign
Number of subjects: 150

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 150
Study: 18448442

Group type: EXPERIMENTAL
Intervention: 0.625‐mg conjugated equine estrogens (CEEs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined analyses of clinical trial and observational study data
Number of subjects: 0
Study: 16204446

Group type: EXPERIMENTAL
Intervention: Psychophysiologically oriented intervention (7 sessions plus 2 assessment sessions)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 43
Study: 14527532

Group type: EXPERIMENTAL
Intervention: Imaginal Exposure (IE)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Active-Imaginal Exposure (AI)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Graduated In Vivo Exposure (IV)
Number of subjects: 82
Study: 10327090

Group type: EXPERIMENTAL
Intervention: Larger and heavier beds (single, double, king) at heights of 460 mm and 560 mm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static models of lifting
Number of subjects: 0
Study: 8959573

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) with nonresorbable membranes
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mucogingival surgery (coronally-positioned free gingival graft)
Number of subjects: 50
Study: 1756286

Group type: EXPERIMENTAL
Intervention: Otilonium bromide (OB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pinaverium bromide
Number of subjects: 40
Study: 7386802

Group type: EXPERIMENTAL
Intervention: Purified allergen preparation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Crude aqueous extract
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 31686430

Group type: EXPERIMENTAL
Intervention: IOP of 15 mmHg (Group I: 32 eyes)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: IOP of 25 mmHg (Group II: 32 eyes)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: IOP of 35 mmHg (Group III: 31 eyes)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Comparison of groups
Number of subjects: 95
Study: 30392140

Group type: EXPERIMENTAL
Intervention: Quiet Eye training group (QET)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control training group (CT)
Number of subjects: 18
Study: 28571271

Group type: COMPARATOR
Intervention: 0.1% triamcinolone acetonide oral paste thrice daily in tapering doses
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: curcumin oral gel thrice daily
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: curcumin oral gel six times daily
Number of subjects: 75
Study: 26451088

Group type: EXPERIMENTAL
Intervention: Probiotic preparation inVag(®) administered vaginally for seven consecutive days
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo administered vaginally for seven consecutive days
Number of subjects: 160
Study: 23339578

Group type: EXPERIMENTAL
Intervention: 4.5 g of larch arabinogalactan preparation (n=101)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo (n=98)
Number of subjects: 199